Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony.
OBJECTIVE
To investigate the prevalence of endometrial inadequacy in endometrial biopsies from women undergoing superovulation with hMG and to correlate these findings with the hormonal milieu.


METHODS
Controlled, retrospective analysis.


METHODS
University-based, tertiary referral, outpatient infertility clinic.


METHODS
Endometrial biopsies were performed during the late luteal phase in 89 women undergoing hMG superovulation combined with IUI. Results were compared with the initial biopsies obtained as part of their routine infertility evaluation.


METHODS
Biopsies were dated by two different observers using standard dating criteria. Serum samples obtained during the midluteal phase were assayed in duplicate for E2 and P levels using commercially available RIAs.


RESULTS
Fifty-seven percent of the endometrial biopsies showed differences in the dating of the glandular epithelium that differed by > 2 days when compared with the stroma. In contrast, only 13% of endometrial biopsies obtained during a nonstimulated cycle showed gland-stroma dyssynchrony. When cycles associated with gland-stroma dyssynchrony were compared with cycles associated with coordinated development of the glands and stroma, no significant differences were observed in E2 level on the day of hCG administration, midluteal serum P, midluteal E2 level, or P:E2 ratios.


CONCLUSIONS
This study demonstrates that when endometrial biopsies are obtained during the late luteal phase in patients undergoing ovarian hyperstimulation there is a significant dyssynchrony in the maturation of the glandular epithelium and the stroma. This may reflect the degree of responsiveness of an individual woman's endometrium rather than a result of the hormonal milieu.
Benadiva
C A
CA
Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington 06030-1230.
Metzger
D A
DA
D000328:Adult; D001706:Biopsy; D004717:Endometrium / Q000033:anatomy & histology / Q000502:physiology*; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D007246:Infertility / Q000628:therapy; D008183:Luteal Phase; D008596:Menotropins / Q000009:adverse effects* / Q000627:therapeutic use; D011374:Progesterone / Q000097:blood; D012189:Retrospective Studies; D013480:Superovulation
D011374:Progesterone; D004958:Estradiol; D008596:Menotropins